logo
Plus   Neg
Share
Email

Microsoft, OpenAI Partner To Build New Azure AI Supercomputing Technologies

Microsoft Corp. (MSFT) said it has formed computing partnership with OpenAI to build new Azure AI supercomputing technologies. They will accelerate breakthroughs in AI and power OpenAI's efforts to create artificial general intelligence. Microsoft will invest $1 billion in OpenAI, which was founded by Tesla Chief Executive Officer Elon Musk and Y Combinator chairman Sam Altman.

Under the partnership, Microsoft and OpenAI will jointly build new Azure AI supercomputing technologies; OpenAI will port its services to run on Microsoft Azure, which it will use to create new AI technologies and deliver on the promise of artificial general intelligence.

Microsoft will become OpenAI's preferred partner for commercializing new AI technologies.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Home Depot Inc. (HD) on Tuesday reported 5.8 percent increase in fourth-quarter profit, while Macy's Inc. (M) fourth-quarter profit fell 54.1 percent. However, the results of the companies beat analysts' estimates. The retailers have reaffirmed their annual outlook. Healthcare insurer Aetna, a subsidiary of CVS Health Corp., announced the launch of Aetna Whole Health in Atlanta, providing fully insured and self-insured health care network options for employers. Aetna said through the program, it will offer the health care network options to its Health Maintenance Organization and Exclusive Product Organization product portfolios. Med Man Distribution expanded its recall for dietary supplements including all lots of "Bow and Arrow libido enhancer for men" for the potential undeclared presence of sildenafil, the U.S. Food and Drug Administration said in a statement. Sildenafil is an FDA-approved prescription drug for erectile dysfunction. The company had earlier in November 2019 recalled all lots of Up2 dietary supplement.
Follow RTT
>